Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Daly

Showing results (391-400 of 511) with videos related to

Pageof 52
Sort By:
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
Breast Cancer Research : BCR|April 20, 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort studyRebecca D Kehm, John L Hopper, Esther M John, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2014
Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityAngela R Bradbury, Linda Patrick-Miller, Jessica Long, et al.
Cancer Research|October 4, 2019
Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic RiskRebecca D Kehm, Jeanine M Genkinger, Robert J MacInnis, et al.
Cancer Research|July 9, 2009
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriersTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.
The Lancet. Oncology|February 26, 2019
10-year performance of four models of breast cancer risk: a validation studyMary Beth Terry, Yuyan Liao, Alice S Whittemore, et al.
Journal of the National Cancer Institute|October 5, 2019
Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation ResultsRobert J MacInnis, Yuyan Liao, Julia A Knight, et al.
JNCI Cancer Spectrum|December 24, 2021
Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial RiskRebecca D Kehm, Robert J MacInnis, Esther M John, et al.
Cell Reports|August 24, 2017
SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous RecombinationWaaqo Daddacha, Allyson E Koyen, Amanda J Bastien, et al.
American Journal of Human Genetics|January 15, 2013
LRIG2 mutations cause urofacial syndromeHelen M Stuart, Neil A Roberts, Berk Burgu, et al.
Pageof 52

Showing results (391-400 of 511) with videos related to

Sort By:
Pageof 52
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
Breast Cancer Research : BCR|April 20, 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort studyRebecca D Kehm, John L Hopper, Esther M John, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2014
Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityAngela R Bradbury, Linda Patrick-Miller, Jessica Long, et al.
Cancer Research|October 4, 2019
Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic RiskRebecca D Kehm, Jeanine M Genkinger, Robert J MacInnis, et al.
Cancer Research|July 9, 2009
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriersTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.
The Lancet. Oncology|February 26, 2019
10-year performance of four models of breast cancer risk: a validation studyMary Beth Terry, Yuyan Liao, Alice S Whittemore, et al.
Journal of the National Cancer Institute|October 5, 2019
Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation ResultsRobert J MacInnis, Yuyan Liao, Julia A Knight, et al.
JNCI Cancer Spectrum|December 24, 2021
Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial RiskRebecca D Kehm, Robert J MacInnis, Esther M John, et al.
Cell Reports|August 24, 2017
SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous RecombinationWaaqo Daddacha, Allyson E Koyen, Amanda J Bastien, et al.
American Journal of Human Genetics|January 15, 2013
LRIG2 mutations cause urofacial syndromeHelen M Stuart, Neil A Roberts, Berk Burgu, et al.
Pageof 52